A joyful celebration to conclude Slovenia's national Clean Teeth and Healthy Nutrition campaign
Today, the 25th annual Slovenian nationwide Clean Teeth and Healthy Nutrition campaign organized by the Dental Section of the Slovenian Medical Association in cooperation with Lek, a Sandoz company, as the general sponsor, and the company Ilirija which assumed the sponsorship within the framework of its acquisition of Lek Cosmetics, came to its close. Nearly 3000 children from all over the country gathered to attend the closing event. There were a number of high-ranking guests, including Zofija Mazej Kukovič, Slovenian Minister of Health, who had assumed honorary sponsorship of this year’s campaign, and Jani Moederndorfer, the Vice-Mayor of the city of Ljubljana.
On the occasion of this important anniversary, special thanks should be given to Tatjana Leskošek Denišlič, the author of the campaign, who first introduced the clean teeth contest to the Kette Murn elementary school in Ljubljana, where she works as the school dentist. The warm applause she received from the children and the guests was unanimous testimony to her commitment.
This year’s campaign involved almost 98 percent (683) of Slovenia’s elementary schools, of which 37 schools and institutions for children with special needs. At the closing ceremony, the sponsors’ representatives presented awards to all the regional winners: elementary schools Žužemberk, 16th December Mojstrana, Negova, Livada, Branik, Artiče, Koroški jeklarji, Poljčane and ZUJL-OVI Jarše. This year’s winning class was a class of 5th grade pupils of the Beltinci elementary school.
In his address to the children and the guests, Marjan Novak, a member of the Lek Management Board, pointed out that Lek pharmaceuticals d.d. was proud to have been able to support this successful campaign, organized for children and unique of its kind in Slovenia, for as long as a quarter of a century.
Glad to receive the awards, the children were further entertained by the program featuring the Hip Hooper acrobatic troupe and the Kingston band, which provided a pleasant and joyful conclusion to this year’s Clean Teeth and Healthy Nutrition campaign.
Lek, a Sandoz company, is one of the pillars of leading world generics company Sandoz. It operates as a global development center for products and technologies, as a global manufacturing center for active pharmaceutical ingredients and medicines, as a competence center for the development of vertically integrated products, as a Sandoz competence center in the field of development and manufacturing of biosimilars and as a supply center for the markets of CEE, SEE and CIS, sales Slovenia and sales services for Sandoz global markets. Lek d.d. employs more than 3,000 people. For further information please consult http://www.lek.si
Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents. Sandoz has a portfolio of more than 950 compounds and sells its products in more than 130 countries. Key product groups include antibiotics, treatments for central nervous system disorders, gastrointestinal medicines, cardiovascular treatments and hormone therapies. Sandoz develops, produces and markets these medicines along with pharmaceutical and biotechnological active substances and anti-infectives. In addition to strong organic growth in recent years, Sandoz has made a series of acquisitions including Lek (Slovenia), Sabex (Canada), Hexal (Germany) and EonLabs (US) In 2007, Sandoz employed around 23,000 people worldwide and posted sales of USD 7.2 billion.
Novartis AG provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on growth areas in healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, and consumer health products. Novartis is the only company with leading positions in these areas. In 2007, the Group’s continuing operations (excluding divestments in 2007) achieved net sales of USD 38.1 billion and net income of USD 6.5 billion. Approximately USD 6.4 billion was invested in R&D activities throughout
the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 98,200 full-time associates and operate in over 140 countries around the world. For more information, please visit http://www.novartis.com.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For further information contact:
Katarina Klemenc Dinjaški
Lek Pharmaceuticals d.d.
Phone: + 386 1 580 22 43
Fax: + 386 1 580 24 32